Actively Recruiting
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
Led by National Cancer Institute, Naples · Updated on 2025-07-29
40
Participants Needed
2
Research Sites
223 weeks
Total Duration
On this page
Sponsors
N
National Cancer Institute, Naples
Lead Sponsor
F
Federico II University
Collaborating Sponsor
AI-Summary
What this Trial Is About
In cancer patients, the integration between anticancer therapies and palliative care is of fundamental importance. In this context, telemedicine can improve the quality of life (QoL) of chronic patients through self-management and remote monitoring solutions. This approach can favor the effectiveness of the treatment and therapeutic adherence. Of note, telemedicine can also be applied to the management of cancer pain. In the advanced stages of cancer disease, pain is one of the most obvious and most disabling symptoms. Consequently, proper pain management has a significant impact on the QoL, the ability to withstand treatment, and the recovery of patients. On the other hand, given the complexity of cancer pain, the main obstacle to its proper management is the lack of adequate measurement methods. Although in recent years a great deal of effort has been made in the direction of automatic pain assessment, both concerning the creation of datasets and the development of classification algorithms, the literature is lacking regarding the automatic measurement of pain in the setting of cancer patients. Observation by experienced clinical staff and self-assessment by patients could be useful for obtaining the ground truth and, in turn, for training automatic pain recognition systems.
CONDITIONS
Official Title
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged > 18 years
- Home care patients diagnosed with advanced cancer disease and life expectancy 64 1 year
- Patients receiving treatment for cancer pain
- Patients who have given their consent
You will not qualify if you...
- Patients aged < 18 years
- Unable to read or write to provide informed consent
- Cognitive deficit such as Alzheimer disease or senile dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National Cancer Institute of Naples
Naples, Campania, Italy, 80131
Actively Recruiting
2
A.O.U. Federico II
Naples, Campania, Italy
Not Yet Recruiting
Research Team
M
Marco Cascella, MD
CONTACT
A
Arturo Cuomo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here